about
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association studyNo evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees.Identification of specific Y chromosomes associated with increased prostate cancer risk.A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer geneticsShared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays.Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families.Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees.Prostate cancer risk prediction based on complete prostate cancer family history.Identification of six loci associated with pelvic organ prolapse using genome-wide association analysisEvidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17.Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses.Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCGEvidence for an Environmental and Inherited Predisposition Contributing to the Risk for Global Tendinopathies or Compression Neuropathies in Patients With Rotator Cuff Tears.Population-based risks for cancer in patients with ALS.Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer GeneticsSignificant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21.Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based studyStatistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms.Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.Evidence for an inherited predisposition contributing to the risk for rotator cuff disease.Population-based risk assessment for other cancers in relatives of hereditary prostate cancer (HPC) cases.Genomic search for prostate cancer predisposition loci in Utah pedigrees.Novel popout with nonsense strings: effects of predictability of string length and spatial location.A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q.Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigreesLocalization of a Prostate Cancer Predisposition Gene to an 880-kb Region on Chromosome 22q12.3 in Utah High-Risk PedigreesCharacterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses:ELAC2 and familial early-onset prostate cancerConfirmation of the HPCX prostate cancer predisposition locus in large Utah prostate cancer pedigreesExamination of ELN as a Candidate Gene in the Utah Intracranial Aneurysm PedigreesIdentification and study of Utah pseudo-isolate populations—prospects for gene identificationConfirmation of chromosome 7q11 locus for predisposition to intracranial aneurysmA simple diagnostic index for asthmaImpact of Correlated Factors on Bone Density in Individuals with a Family History of Osteoporosis
P50
Q29417074-82B9EBD7-3059-40D8-A3F4-C437420E888EQ33454990-D1B53793-CD9A-4CB7-B8BB-5F1A2A07F2FFQ33944643-A167E506-89D6-42CA-920B-B094630D92EBQ34015399-2F7B3DA0-9C49-4A9F-971F-2D18BB2C7C70Q34241688-28D2A376-11C0-4524-B36E-D224D7662DE6Q34308746-3853CA5D-B7FD-40AA-BFBA-F158FEE0C36AQ34494526-097D4017-53A4-4084-9CBF-650822A353D1Q34944738-FBE8BC53-BC6D-4902-ADA6-15D58C56184FQ35599982-6492272E-0092-4700-9D05-9EBDB59DDAB4Q35688980-1DD31CEA-E1EE-4F36-AD9F-459BEE268053Q36190531-31B39B24-57B3-49C6-B1A7-FCF3851D7D4DQ36502322-C8014C8E-4899-4A4C-AAFA-8F8CCB46CDFDQ36599631-B1D6AE72-7AF6-480F-8606-D10D26BD12D6Q36796431-8A7C1C15-D0D3-4995-87F8-F144E1FB357FQ37113358-0D384030-D740-4D51-A59E-AC49D8CFA5AEQ37121925-60CCE880-EE3C-4795-9E70-71CA7851106EQ37189147-9A0B9332-9AC0-43EB-9281-2593A28128C3Q37229978-334667B6-6E20-4C20-A09E-1AE0457E2D8DQ40190172-4189070E-E311-46A1-802B-62E0A1CD723FQ40561180-6B41B007-6BB7-465C-9F53-2B622E006FECQ40718874-ABFB9D64-26BB-4272-AFF4-EAA8252F7D79Q41947566-31301651-4C01-4DDD-B86B-DD6AF47DA1AAQ43791618-EABD07AE-388B-4F9F-B692-A2FDF2818CEFQ45105954-1A4A2C52-110F-47D5-9328-843BAEC4225CQ52218044-5D4B88FC-0362-43AB-A91E-B688F08C964EQ53237784-6765E49C-756B-4207-945B-2F71BB994DD7Q59548761-4C8E7522-1AA2-4105-BEAE-50E887DC0D99Q59548773-BC704FEC-13AC-45A8-89D1-D4C82DF2D751Q59548776-F754D253-DD9B-4464-95CC-25B4D1609956Q59548777-CA2842BE-6D41-4D96-9CB3-09DC7D62B557Q59548778-BB67C9AB-1F7C-4904-925E-9AD35FF750B1Q59548787-7D01DF4B-C5B6-4038-996E-3ED4978376D9Q59548803-C9BEAD1D-3403-4671-8C27-33602B4CE866Q59548815-792AC89E-DA94-4454-8BCD-6846DC7663B9Q59548819-C467679F-8043-4E45-8FE4-66A06F222691
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
James Farnham
@ast
James Farnham
@en
James Farnham
@es
James Farnham
@nl
type
label
James Farnham
@ast
James Farnham
@en
James Farnham
@es
James Farnham
@nl
prefLabel
James Farnham
@ast
James Farnham
@en
James Farnham
@es
James Farnham
@nl
P108
P106
P1153
35375069400
P21
P31
P496
0000-0002-8213-949X